Potential Therapeutics in COVID-19/SARS-CoV-2
- Scientific, medical, or healthcare background
This course covers Potential New Therapeutics that may be effective in the current SARS-COV-2 COVID-19 coronavirus pandemic.
Topics include virus-targeted agents and host targeted agents, including clinical trial data on hydroxychloroquine/azithromycin, favipiravir, convalescent sera, and others. The pharmacology and mechanism of action of these approaches are described. Contents are based on the latest medical research literature in PubMed and are intended for a science-savvy audience.
Our content creators have MDs, PhDs, PharmDs, and other advanced degrees. They have combined their years of expertise with research on the latest scientific info that may be helpful during this pandemic.
- People with an understanding of science
- COVID-19 background05:46
- Drug Repurposing02:01
- Virus-Targeted Agents11:34
- Host-Targeted Agents03:27
- On the Horizon02:49
- ACEis and ARBs01:58
- Drug-Drug Interactions02:13
- Listing of Current Therapeutics1 question
Emma Nichols, PhD, is a long time writer specializing in medical topics. While working in a lab earning her PhD in molecular biology, she realized she would much rather write about science than "do" science and has been a medical writer ever since. She has a passion for teaching people about medical writing and communicating all things medical.